Abstract
Rhenium-188 has a half life of 17 h and can be stored and/or transported prior to preparation of the labelled compounds. However, the radiolysis within the aqueous solutions can result in changes in the suitability of the perrhenate solution for use in the preparation of the labelled compound. This paper reports a study of the production of the major radiolysis product, hydrogen peroxide, its effect on the formation of one radiopharmaceutical together with the results of various attempts to limit or eliminate these effects.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
